Rogers DF: Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care 2007, 52: 1134–1146.
Google Scholar
Lopez-Vidriero MT: Airway mucus: production and composition. Chest 1981, 80(Suppl):799–804.
CAS
Google Scholar
Voynow JA, Rubin BK: Mucins, mucus, and airway secretions. CHEST 2009, 135: 505–512. 10.1378/chest.08-0412
Article
CAS
Google Scholar
Tomkiewicz RP, Kishioka C, Freeman J, Rubin BK: DNA and actin filament ultrastructure in cystic fibrosis sputum. In Cilia, Mucus and Mucociliary Interactions. Edited by: Baum G. New York: Marcel Dekker; 1998:333–341.
Google Scholar
Henke MO, Renner A, Huber RM, Seeds MC, Rubin BK: MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 2004, 31: 86–91. 10.1165/rcmb.2003-0345OC
Article
CAS
Google Scholar
Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin BK: Serine proteases degrade airway mucins in cystic fibrosis. Infect Immun 2011, 79(8):3438–3444. 10.1128/IAI.01252-10
Article
CAS
Google Scholar
Wanner A, Salathé M, O’Riordan TG: Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996, 154: 1868–1902. 10.1164/ajrccm.154.6.8970383
Article
CAS
Google Scholar
Kishioka C, Okamoto K, Kim JS, Rubin BK: Regulation of secretion from mucous and serous cells in the excised ferret trachea. Resp Physiol 2001, 126: 163–171. 10.1016/S0034-5687(01)00214-6
Article
CAS
Google Scholar
Boucher RC: State of the art: human airway ion transport. Am J Respir Crit Care Med 1994, 150: 271–281. and 581–593 10.1164/ajrccm.150.1.8025763
Article
CAS
Google Scholar
King M, Rubin BK: Pharmacological approaches to discovery and development of new mucolytic agents. Advanced Drug Delivery Rev 2002, 54: 1475–1490. 10.1016/S0169-409X(02)00156-4
Article
CAS
Google Scholar
King M, Rubin BK: Mucus rheology, relationship with transport. In Airway secretion: Physiological Bases for the Control of Mucus Hypersecretion. Edited by: Takishima T. New York: Marcel Dekker, Inc; 1994:283–314.
Google Scholar
King M, Brock G, Lundell C: Clearance of mucus by simulated cough. J Appl Physiol 1985, 58: 1776–1782.
CAS
Google Scholar
Rubin BK: Surface properties of respiratory secretions: relationship to mucus transport. In Cilia, Mucus, and Mucociliary Interactions. Edited by: Baum G. New York: Marcel Dekker; 1998:317–324.
Google Scholar
Albers GM, Tomkiewicz RP, May MK, Ramirez OE, Rubin BK: Ring distraction technique for measuring surface tension of sputum: relationship to sputum clearability. J Appl Physiol 1996, 81: 2690–2695.
CAS
Google Scholar
Agarwal M, King M, Rubin BK, Shukla JB: Mucus transport in a miniaturized simulated cough machine: effect of constriction and serous layer simulant. Biorheology 1988, 26: 977–988.
Google Scholar
Rubin BK: Immotile cilia syndrome (primary ciliary dyskinesia) and airways inflammation. Clin Chest Med 1988, 9: 657–668.
CAS
Google Scholar
Rubin BK, Ramirez O, King M: Mucus-depleted frog palate as a model for the study of mucociliary clearance. J Appl Physiol 1990, 69: 424–429.
CAS
Google Scholar
Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK: Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest 2006, 129: 118–123. 10.1378/chest.129.1.118
Article
Google Scholar
Rubin BK: CFTR is a modulator of airway inflammation. Am J Physiol Lung Cell and Molec Physiol 2008, 2: L381-L382.
Google Scholar
Rubin BK: Mucus structure and properties in cystic fibrosis. Paed Resp Rev 2007, 8: 1–7.
Google Scholar
Girod S, Galabert C, Lecuire A, Zahm JM, Puchelle E: Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases. Pediatr Pulmonol 1992, 13: 22–27. 10.1002/ppul.1950130107
Article
CAS
Google Scholar
Tarran R, Button B, Boucher RC: Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol 2006, 68: 543–561. 10.1146/annurev.physiol.68.072304.112754
Article
CAS
Google Scholar
Henke MO, Gerrit J, Germann M, Lindemann H, Rubin BK: MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during a pulmonary exacerbation. Am J Resp Crit Care Med 2007, 175: 816–821. 10.1164/rccm.200607-1011OC
Article
CAS
Google Scholar
Rubin BK, MacLeod PM, Sturgess JM, King M: Recurrent respiratory infections in a child with fucosidosis: Is the mucus too thin for effective transport? Ped Pulmonol 1991, 10: 304–309. 10.1002/ppul.1950100415
Article
CAS
Google Scholar
King M, El-Azab J, Phillips DM, Angus GE: Antigen challenge and canine tracheal mucus. Int Arch Allergy Appl Immunol 1985, 77: 337–342. 10.1159/000233841
Article
CAS
Google Scholar
Rogers DF: Airway mucus hypersecretion in asthma: an undervalued pathology? Curr Opin Pharmacol 2004, 4: 241–250. 10.1016/j.coph.2004.01.011
Article
CAS
Google Scholar
Rubin BK, Tomkiewicz R, Fahy JV, Green FY: Histopathology of fatal asthma. Drowning in mucus. Pedes Pulmonol 2001, 23: 88–89S.
Article
Google Scholar
Sheehan JK, Richardson PS, Fung DC, Howard M, Thornton DJ: Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol 1995, 13: 748–756. 10.1165/ajrcmb.13.6.7576713
Article
CAS
Google Scholar
Kuyper LM, Pare PD, Hogg JC, Lambert RK, Ionescu D, Woods R, Bai TR: Characterization of airway plugging in fatal asthma. Am J Med 2003, 115: 6–11.
Article
Google Scholar
Kanoh S, Tanabe T, Rubin BK: IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells. Clin Exp Allergy 2011, 41: 1747–1756. 10.1111/j.1365-2222.2011.03852.x
Article
CAS
Google Scholar
Tanabe T, Kanoh S, Tsushima K, Yamazaki Y, Kubo K, Rubin BK: Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. Am J Respir Cell Mol Biol 2011, 45: 1075–1083. 10.1165/rcmb.2010-0327OC
Article
CAS
Google Scholar
Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ, Hamid Q: Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997, 155: 845–851. 10.1164/ajrccm.155.3.9117015
Article
CAS
Google Scholar
Saha SK, Berry MA, Parker D, Siddiqui S, Morgan A, May R, Monk P, Bradding P, Wardlaw AJ, Pavord ID, Brightling CE: Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol 2008, 121: 685–691. 10.1016/j.jaci.2008.01.005
Article
CAS
Google Scholar
Okamoto K, Kim JS, Rubin BK: Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea. Am J Physiol 2007, 292(1):L62-L67.
CAS
Google Scholar
Hite RD, Seeds MC, Jacinto RB, Balasubramanian R, Waite M, Bass D: Hydrolysis of surfactant-associated phosphotidylcholine by mammalian secretory phospholipases A2. Am J Physiol 1998, 275(Lung Cell Mol Physiol 19):L740-L747.
CAS
Google Scholar
Rubin BK, Ramirez O, Zayas JG, Finegan B, King M: Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action. Am Rev Respir Dis 1992, 145: 545–547. 10.1164/ajrccm/145.3.545
Article
CAS
Google Scholar
Vestbo J, Prescott E, Lange P: Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996, 153: 1530–1535. 10.1164/ajrccm.153.5.8630597
Article
CAS
Google Scholar
Fahy JV, Dickey BF: Airway mucus function and dysfunction. N Engl J Med 2010, 363: 2233–2247. 10.1056/NEJMra0910061
Article
CAS
Google Scholar
Zayas JG, Rubin BK, York EL, Lien DC, King M: Bronchial mucus properties in lung cancer: relationship with site of lesion. Canadian Resp J 1999, 6(3):246–252.
CAS
Google Scholar
Redding GJ, Kishioka C, Martinez P, Rubin BK: Physical and transport properties of sputum from Alaskan native children with bronchiectasis. Chest 2008, 134: 1129–1134. 10.1378/chest.08-0296
Article
Google Scholar
Madsen P, Shah SA, Rubin BK: Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev 2005, 6: 292–300. 10.1016/j.prrv.2005.09.001
Article
Google Scholar
Rubin BK, Moskowitz WB: Plastic bronchitis. In the ERS Handbook of Paediatric Respiratory Medicine. Edited by: Ernst E, Fabio M. Sheffield, UK: European Respiratory Society Publications; 2013:577–581.
Google Scholar
Rubin BK: Taxonomy of mucoactive medications. In Therapy for Mucus Clearance Disorders. Edited by: Rubin BK, van der Schans CP. New York: Marcel Dekker, Inc; 2004:129–146.
Chapter
Google Scholar
Rubin BK: Mucolytics, expectorants, and mucokinetic medications. Resp Care 2007, 52: 859–865.
Google Scholar
Jager EG: Double-blind, placebo-controlled clinical evaluation of guaimesal in outpatients. Clin Ther 1989, 11: 341–362.
CAS
Google Scholar
Rubin BK, Ramirez O, Ohar JA: Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. Chest 1996, 109: 348–352. 10.1378/chest.109.2.348
Article
CAS
Google Scholar
Hoffer-Schaefer A, Rozycki HJ, Yopp MA, Rubin BK: Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with an acute respiratory tract infection. Resp Care 2014. (in press) PMID:24003241
Google Scholar
Wark PA, McDonald V, Jones AP: Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev 2005., 3: CD001506
Google Scholar
Kishioka C, Okamoto K, Kim JS, Rubin BK: Hyperosmolar solutions stimulate mucus secretion in the ferret trachea. Chest 2003, 124: 306–313. 10.1378/chest.124.1.306
Article
CAS
Google Scholar
Daviskas E, Anderson SD, Gomes K, Briffa P, Cochrane B, Chan HK, Young IH, Rubin BK: Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis - effect on lung function, health status and sputum. Respirology 2005, 10: 46–56. 10.1111/j.1440-1843.2005.00659.x
Article
Google Scholar
Daviskas E, Rubin BK: Effect of inhaled dry powder mannitol on mucus and its clearance. Expert Rev Respir Med 2013, 7: 65–75. 10.1586/ers.12.72
Article
CAS
Google Scholar
Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C: Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet 2001, 20(358):1316–1321.
Article
Google Scholar
Rogers DF, Rubin BK: Mucolytics for COPD. In Chronic Obstructive Pulmonary Disease. Edited by: Stockley RA, Steven R, Klaus R, Bartolome C. Oxford: Blackwell Publishing; 2006.
Google Scholar
Decramer M, Rutten-van Mölken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005, 365: 1552–1560. 10.1016/S0140-6736(05)66456-2
Article
CAS
Google Scholar
Cotgreave IA, Eklund A, Larsson K, Moldeus PW: No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid. Eur J Respir Dis 1987, 70: 73–77.
CAS
Google Scholar
Dano G: Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergol 1971, 26: 181–190. 10.1111/j.1398-9995.1971.tb01294.x
Article
CAS
Google Scholar
Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME: Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994, 331: 637–642. 10.1056/NEJM199409083311003
Article
CAS
Google Scholar
Laube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ: Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am J Respir Crit Care Med 1996, 153: 752–760. 10.1164/ajrccm.153.2.8564129
Article
CAS
Google Scholar
Rubin BK: Who will benefit from DNase? Pediatr Pulmonol 1999, 27: 3–4.
Article
CAS
Google Scholar
Rubin BK, Kater AP, Goldstein AL: Thymosin β4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro . Chest 2006, 130: 1433–1440.
Google Scholar
Rubin BK, Ramirez O, King M: Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest 1992, 101: 1080–1085. 10.1378/chest.101.4.1080
Article
CAS
Google Scholar
Anzueto A, Jubran A, Ohar JA, Piquette CA, Rennard SI, Colice G, Pattishall EN, Barrett J, Engle M, Perret KA, Rubin BK: Effects of aerosolized surfactant in patients with stable chronic bronchitis. A prospective randomized controlled trial. J Am Med Assoc 1997, 278: 1426–1431. 10.1001/jama.1997.03550170056032
Article
CAS
Google Scholar
Bateman ED, Rennard S, Barnes PJ, Dicpinigaitis PV, Gosens R, Gross NJ, Nadel JA, Pfeifer M, Racké K, Rabe KF, Rubin BK, Welte T, Wessler I: Alternative mechanisms for tiotropium. Pulm Pharm Therapeutics 2009, 22: 533–542. 10.1016/j.pupt.2009.06.002
Article
CAS
Google Scholar
Tamaoki J, Chiyotani A, Tagaya E, Sakai N, Konno K: Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis. Thorax 1994, 49: 545–548. 10.1136/thx.49.6.545
Article
CAS
Google Scholar
Hasani A, Toms N, Agnew JE, Sarno M, Harrison AJ, Dilworth P: The effect of inhaled tiotropium bromide on lung mucociliary clearance in patients with COPD. Chest 2004, 125: 1726–1734. 10.1378/chest.125.5.1726
Article
CAS
Google Scholar
Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T: Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis 1992, 145: 548–552. 10.1164/ajrccm/145.3.548
Article
CAS
Google Scholar
López-Boado YS, Rubin BK: Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opinion Pharmacol 2008, 8: 286–289. 10.1016/j.coph.2008.01.010
Article
Google Scholar
Rubin BK, Tamaoki J: Macrolide antibiotics as biological response modifiers. Curr Opin Investig Drugs 2000, 1: 169–172.
CAS
Google Scholar
Rubin BK: Immunomodulatory properties of macrolides: overview and historical perspective. Am J Med 2004, 117: 2S-4S.
Google Scholar
Shinkai M, Park CS, Rubin BK: Immunomodulatory effects of macrolide antibiotics. Clin Pulm Med 2005, 12: 341–349. 10.1097/01.cpm.0000187294.53696.c0
Article
Google Scholar
Shinkai M, Foster GH, Rubin BK: Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol 2006, 290: L75-L85.
CAS
Google Scholar
Rubin BK, Henke MO: Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest 2004, 125(2 Suppl):70S-78S.
Article
CAS
Google Scholar
Southern KW, Barker PM, Solis A: Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2004, 2: CD002203.
Google Scholar
Strickland SL, Rubin BK, Drescher GS, Haas CF, O’Malley CA, Volsko TA, Branson RD, Hess DR: AARC Clinical practice guideline: effectiveness of nonpharmacologic airway clearance techniques in hospitalized patients. Respir Care 2013, 58: 2187–2193. 10.4187/respcare.02925
Article
Google Scholar
Rubin BK: Designing clinical trials to evaluate mucus clearance therapy. Respir Care 2007, 52: 1348–1361.
Google Scholar